IXHL · Incannex Healthcare Limited

Summary

Incannex Healthcare Inc. terminated a material definitive agreement previously amended on May 27, 2025, issued a press release on March 12, 2026 announcing its enhanced Phase 2 dose-optimisation study, and furnished a corporate presentation as Exhibit 99.1.

Key takeaways

• Termination of material definitive agreement previously disclosed and amended on May 27, 2025.
• Press release issued on March 12, 2026 announcing enhanced Phase 2 dose-optimisation study.
• Exhibit 99.1: Corporate Presentation dated March 12, 2026.
• Exhibit 99.2: Press Release of Incannex Healthcare.